SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-016436
Filing Date
2023-05-02
Accepted
2023-05-02 07:21:17
Documents
58
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sage-20230331.htm   iXBRL 10-Q 3029168
2 EX-10.1 sage-ex10_1.htm EX-10 43934
3 EX-10.2 sage-ex10_2.htm EX-10 26893
4 EX-31.1 sage-ex31_1.htm EX-31 13984
5 EX-31.2 sage-ex31_2.htm EX-31 13963
6 EX-32.1 sage-ex32_1.htm EX-32 13002
7 GRAPHIC img93198881_0.jpg GRAPHIC 606059
  Complete submission text file 0000950170-23-016436.txt   12366733

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT sage-20230331_cal.xml EX-101.CAL 42475
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT sage-20230331_def.xml EX-101.DEF 212736
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sage-20230331.xsd EX-101.SCH 49005
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sage-20230331_lab.xml EX-101.LAB 415875
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sage-20230331_pre.xml EX-101.PRE 317006
52 EXTRACTED XBRL INSTANCE DOCUMENT sage-20230331_htm.xml XML 2534781
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 23876610
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences